Pharmaceutical discount agreement Triptorelin
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Triptorelin, ATC L02AE04
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Automatic termination if national or regional discount agreements for Triptorelin are concluded.
No minimum volume or value commitment.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jun 2028
- Non-exclusive discount agreements for Triptorelin (ATC L02AE04) with pharmaceutical companies.
- Open house model - any eligible company can join.
Show full summary
Non-exclusive open house model for discount agreements on the active substance Triptorelin (ATC L02AE04) by AOK Bayern. All pharmaceutical companies meeting eligibility can join. No estimated value provided. Duration from July 2026 to June 2028. Submissions possible until May 2028 with monthly cutoffs.
Risks
Automatic termination if national or regional discount agreements for Triptorelin are concluded.
No minimum volume or value commitment.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical company.
Administrative
- Submission of signed self-declaration of reliability.
- Submission of signed contract and annex specifying the medicinal products.
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Pharmaceutical discount agreement Triptorelin
Open house model for non-exclusive discount agreements on Triptorelin (ATC L02AE04) for pharmaceutical companies. Duration 24 months, with entry possible from July 2026.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria - all eligible companies are accepted.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Triptorelin, ATC L02AE04
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 17 May 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 338313-2026
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Automatic termination if national or regional discount agreements for Triptorelin are concluded.
No minimum volume or value commitment.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications